BMC Medical Genomics最新文献

筛选
英文 中文
The role of NOS3-rs1799983 and NOS3- rs2070744 SNP in occurrence of avascular necrosis as a post COVID-19 complication. NOS3-rs1799983和NOS3-rs2070744 SNP在COVID-19后并发症血管坏死中的作用。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-21 DOI: 10.1186/s12920-024-01928-1
Eman Abd Allah Mahmoud Fouda, Eman Ae Badr, Doaa Gawesh, Mohammad A Mahmoud
{"title":"The role of NOS3-rs1799983 and NOS3- rs2070744 SNP in occurrence of avascular necrosis as a post COVID-19 complication.","authors":"Eman Abd Allah Mahmoud Fouda, Eman Ae Badr, Doaa Gawesh, Mohammad A Mahmoud","doi":"10.1186/s12920-024-01928-1","DOIUrl":"10.1186/s12920-024-01928-1","url":null,"abstract":"<p><p>Avascular necrosis (AVN) is a debilitating condition characterized by bone tissue death due to inadequate blood supply, leading to joint dysfunction and collapse. This study investigates the potential association between AVN and COVID-19, focusing on genetic factors such as NOS3 polymorphisms. A total of 180 individuals were included, comprising 120 COVID-19 patients and 60 healthy controls. Clinical, haematological, biochemical, and genetic parameters were assessed. Results revealed significant differences in respiratory and heart rates, haematological counts, and biochemical markers between AVN and control groups. Genetic analysis showed a higher prevalence of the TG genotype and G allele in NOS3 rs1799983 polymorphism among AVN patients. Additionally, NOS3 rs2070744 polymorphism correlated with various clinical parameters, including blood pressure, heart rate, and haematological indices. This study highlights the potential role of genetic factors in predisposing individuals to AVN following COVID-19 infection.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"217"},"PeriodicalIF":2.1,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma. 综合生物信息学分析和实验验证揭示了ALOX5AP与胶质瘤预后和免疫微环境之间的关系。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-21 DOI: 10.1186/s12920-024-01991-8
Ping Song, Hui Deng, Yushu Liu, Mengxian Zhang
{"title":"Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma.","authors":"Ping Song, Hui Deng, Yushu Liu, Mengxian Zhang","doi":"10.1186/s12920-024-01991-8","DOIUrl":"10.1186/s12920-024-01991-8","url":null,"abstract":"<p><strong>Background: </strong>Treatment of gliomas, the most prevalent primary malignant neoplasm of the central nervous system, is challenging. Arachidonate 5-lipoxygenase activating protein (ALOX5AP) is crucial for converting arachidonic acid into leukotrienes and is associated with poor prognosis in multiple cancers. Nevertheless, its relationship with the prognosis and the immune microenvironment of gliomas remains incompletely understood.</p><p><strong>Methods: </strong>The differential expression of ALOX5AP was evaluated based on public Databases. Kaplan-Meier, multivariate Cox proportional hazards regression analysis, time-dependent receiver operating characteristic, and nomogram were used to estimate the prognostic value of ALOX5AP. The relationship between ALOX5AP and immune infiltration was calculated using ESTIMATE and CIBERSORT algorithms. Relationships between ALOX5AP and human leukocyte antigen molecules, immune checkpoints, tumor mutation burden, TIDE score, and immunophenoscore were calculated to evaluate glioma immunotherapy response. Single gene GSEA and co-expression network-based GO and KEGG enrichment analysis were performed to explore the potential function of ALOX5AP. ALOX5AP expression was verified using multiplex immunofluorescence staining and its prognostic effects were confirmed using a glioma tissue microarray.</p><p><strong>Result: </strong>ALOX5AP was highly expressed in gliomas, and the expression level was related to World Health Organization (WHO) grade, age, sex, IDH mutation status, 1p19q co-deletion status, MGMTp methylation status, and poor prognosis. Single-cell RNA sequencing showed that ALOX5AP was expressed in macrophages, monocytes, and T cells but not in tumor cells. ALOX5AP expression positively correlated with M2 macrophage infiltration and poor immunotherapy response. Immunofluorescence staining demonstrated that ALOX5AP was upregulated in WHO higher-grade gliomas, localizing to M2 macrophages. Glioma tissue microarray confirmed the adverse effect of ALOX5AP in the prognosis of glioma.</p><p><strong>Conclusion: </strong>ALOX5AP is highly expressed in M2 macrophages and may act as a potential biomarker for predicting prognosis and immunotherapy response in patients with glioma.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"218"},"PeriodicalIF":2.1,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis. 肠道微生物群对肝性脑病的因果效应:泯灭随机分析。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-19 DOI: 10.1186/s12920-024-01939-y
Jia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, Xin-Yi Deng, Jia-Jun Deng, Tsz Yu Lau, Shi-Yu Cao, Hui-Ying Ran, Zai-Bo Jiang, Jun-Yang Luo
{"title":"The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis.","authors":"Jia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, Xin-Yi Deng, Jia-Jun Deng, Tsz Yu Lau, Shi-Yu Cao, Hui-Ying Ran, Zai-Bo Jiang, Jun-Yang Luo","doi":"10.1186/s12920-024-01939-y","DOIUrl":"10.1186/s12920-024-01939-y","url":null,"abstract":"<p><strong>Background: </strong>There is growing evidence for a relationship between gut microbiota and hepatic encephalopathy (HE). However, the causal nature of the relationship between gut microbiota and HE has not been thoroughly investigated.</p><p><strong>Method: </strong>This study utilized the large-scale genome-wide association studies (GWAS) summary statistics to evaluate the causal association between gut microbiota and HE risk. Specifically, two-sample Mendelian randomization (MR) approach was used to identify the causal microbial taxa for HE. The inverse variance weighted (IVW) method was used as the primary MR analysis. Sensitive analyses were performed to validate the robustness of the results.</p><p><strong>Results: </strong>The IVW method revealed that the genus Bifidobacterium (OR = 0.363, 95% CI: 0.139-0.943, P = 0.037), the family Bifidobacteriaceae (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039), and the order Bifidobacteriales (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039) were negatively associated with HE. However, no causal relationship was observed among them after the Bonferroni correction test. Neither heterogeneity nor horizontal pleiotropy was found in the sensitivity analysis.</p><p><strong>Conclusion: </strong>Our MR study demonstrated a potential causal association between Bifidobacterium, Bifidobacteriaceae, and Bifidobacteriales and HE. This finding may provide new therapeutic targets for patients at risk of HE in the future.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"216"},"PeriodicalIF":2.1,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment the carrier frequency of monogenic diseases in populations requiring assisted reproductive technology. 评估需要辅助生殖技术的人群中单基因疾病的携带频率。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-19 DOI: 10.1186/s12920-024-01989-2
Xiuhua Xu, Sijie He, Gang Li, Ziwei Wang, Luyi Lv, Zhiming Zhao, Qian Li, Baojun Shi, Gui-Min Hao
{"title":"Assessment the carrier frequency of monogenic diseases in populations requiring assisted reproductive technology.","authors":"Xiuhua Xu, Sijie He, Gang Li, Ziwei Wang, Luyi Lv, Zhiming Zhao, Qian Li, Baojun Shi, Gui-Min Hao","doi":"10.1186/s12920-024-01989-2","DOIUrl":"10.1186/s12920-024-01989-2","url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study is to assess the carrier frequency and pathogenic variation of monogenetic diseases in a population of 114 subjects in Han Chinese from Hebei province who are undergoing assisted reproductive technology through the utilization of Expanded Carrier Screening (ECS).</p><p><strong>Methods: </strong>The study utilized a panel consisting of 155 severe monogenic recessive genetic diseases for ECS. Next-generation sequencing technology was employed to identify specific variants associated with ECS in a cohort of 114 subjects from 97 couples, comprising 97 females and 17 male spouses.</p><p><strong>Results: </strong>A total of 114 individuals received ECS. The carrier rate of pathogenic genes in the enrolled population was 44.74% (51/114). Among the 97 females, the carrier rate of pathogenic genes was higher in those without assisted reproduction indicators than in those with assisted reproduction indicators (59.09% vs. 41.33%). However, the carrier rate of pathogenic genes in males without assisted reproductive technology was slightly lower than that with assisted reproductive technology (40% vs. 41.67%). Among both female and male participants, the carrier rate of pathogenic genes between individuals without indicators of assisted reproduction and those with such indicators was 55.55% vs. 41.38%. In 51 carriers, 72.55% (37/51) carried one genetic variant, 25.49% (13/51) carried two genetic variants, and 1.96% (1/51) carried three genetic variants. A total of 38 pathogenic genes were detected in this study, and GJB2 and MMACHC were most common. The carrier rates of the two genes were both 5.26% (6/114). A total of 55 variations were detected, and c.235delC was most frequently found. The carrier rate was 3.51% (4/114). The incidence of couples carrying the same pathogenic genes was 1.03% (1/97).</p><p><strong>Conclusions: </strong>The findings elucidate the carrier rate of pathogenic genes among 155 severe monogenic recessive genetic diseases and underscore the significance of ECS as a preventive measure against congenital anomalies. When both partners carry the same genetic mutation for a monogenic disease, preventive strategies can be taken in offspring through preimplantation genetic testing (PGT), prenatal genetic testing, or the utilization of donor gametes. ECS is instrumental in assessing reproductive risk, guiding fertility-related decisions, and reducing the prevalence of monogenic recessive genetic disorders in subsequent generations.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"214"},"PeriodicalIF":2.1,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer. 病例报告:对免疫疗法的反应以及遗传性骨髓瘤病和肾细胞癌相关肾细胞癌中 fh 基因的关联。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-19 DOI: 10.1186/s12920-024-01957-w
Fangfang Gao, Dejian Gu, He Zhang, Chao Shi, Feng Du, Bo Zheng, Huijuan Wu, Yanqiu Zhao
{"title":"Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer.","authors":"Fangfang Gao, Dejian Gu, He Zhang, Chao Shi, Feng Du, Bo Zheng, Huijuan Wu, Yanqiu Zhao","doi":"10.1186/s12920-024-01957-w","DOIUrl":"10.1186/s12920-024-01957-w","url":null,"abstract":"<p><p>Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant syndrome caused by a germline mutation in the fumarate hydratase (FH) gene that manifests with cutaneous leiomyomas, uterine fibroids, and renal cell cancer (RCC). Patients with HLRCC-associated RCC (HLRCC-RCC) have aggressive clinical courses, but there is no standardized therapy for advanced HLRCC-RCC. In this study, we described a case of aggressive HLRCC in a 33-year-old female who exhibited a novel heterozygous germline insertion mutation in exon 8 of the FH gene (c.1126 C > T; p.Q376*). The patient underwent laparoscopic resection of the right kidney, but metastases appeared within 3 months after surgery. Histological staining of the resected tumor revealed high expression levels of programmed cell death-ligand 1 (PD-L1). Therefore, the patient was treated with immunotherapy. The patient achieved a partial response to immunotherapy, and the treatment of metastatic lesions has continued to improve. A thorough literature review pinpointed 76 historical cases of HLRCC-RCC that had undergone immunotherapy. From this pool, 46 patients were selected for this study to scrutinize the association between mutations in the FH gene and the effectiveness of immunotherapy. Our results indicate that immunotherapy could significantly improve the overall survival (OS) of patients with HLRCC-RCC. However, no influence of different mutations in the FH germline gene on the therapeutic efficacy of immunotherapy was observed. Therefore, our study suggested that immunotherapy was an effective therapeutic option for patients with HLRCC regardless of the type of FH germline mutation.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"215"},"PeriodicalIF":2.1,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe pulmonary arterial hypertension in congenital sideroblastic anemia from PUS1 mutation - a case report. PUS1 基因突变导致先天性红细胞性贫血的重度肺动脉高压--病例报告。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-15 DOI: 10.1186/s12920-024-01983-8
Shyam S Kothari, Jayal Shah, Vishal Sharma, Riyaz Charaniya, Rujuta Parikh, Salil N Vaniawala
{"title":"Severe pulmonary arterial hypertension in congenital sideroblastic anemia from PUS1 mutation - a case report.","authors":"Shyam S Kothari, Jayal Shah, Vishal Sharma, Riyaz Charaniya, Rujuta Parikh, Salil N Vaniawala","doi":"10.1186/s12920-024-01983-8","DOIUrl":"10.1186/s12920-024-01983-8","url":null,"abstract":"<p><strong>Background: </strong>Myopathy, lactic acidosis and inherited sideroblastic anemia (MLASA) are a group of rare intriguing disorders with wider pathophysiological implications. One of the causes of MLASA is the mutation in PUS1 gene that encodes for pseudouridine synthase. This PUS1 mutation results in MLASA in which anemia and myopathy predominate. Severe pulmonary arterial hypertension has not been previously reported in patients with PUS1 gene mutation.</p><p><strong>Case report: </strong>A 17 year old girl with congenital sideroblastic anemia presented with worsening of breathlessness. Severe pulmonary artery hypertension was documented on investigations. A homozygous variant in exon 3 of gene PUS1,( chromosome 12:g.131932301 C > T c.430 C > T) was found on sanger sequencing.</p><p><strong>Conclusion: </strong>We document severe pulmonary arterial hypertension in a patient of congenital sideroblastic anemia from PUS1 gene. We hypothesis that cross talk with TGFb pathways might occur in PUS1 mutation, and that might cause severe PAH. This observation might have therapeutic implications.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"213"},"PeriodicalIF":2.1,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic characterization of methicillin-resistant Staphylococcus aureus isolated from patients attending regional referral hospitals in Tanzania. 从坦桑尼亚地区转诊医院病人中分离出的耐甲氧西林金黄色葡萄球菌的基因组特征。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-14 DOI: 10.1186/s12920-024-01979-4
Mujungu A Geofrey, Elingarami Sauli, Livin E Kanje, Melkiory Beti, Mariana J Shayo, Davis Kuchaka, Marco van Zwetselaar, Boaz Wadugu, Blandina Mmbaga, Sixbert Isdory Mkumbaye, Happiness Kumburu, Tolbert Sonda
{"title":"Genomic characterization of methicillin-resistant Staphylococcus aureus isolated from patients attending regional referral hospitals in Tanzania.","authors":"Mujungu A Geofrey, Elingarami Sauli, Livin E Kanje, Melkiory Beti, Mariana J Shayo, Davis Kuchaka, Marco van Zwetselaar, Boaz Wadugu, Blandina Mmbaga, Sixbert Isdory Mkumbaye, Happiness Kumburu, Tolbert Sonda","doi":"10.1186/s12920-024-01979-4","DOIUrl":"10.1186/s12920-024-01979-4","url":null,"abstract":"<p><strong>Background: </strong>Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases the risk of subsequent infection by MRSA strain complex interlinking between hospital and community-acquired MRSA which increases the chance of drug resistance and severity of the disease.</p><p><strong>Objective: </strong>Genomic characterization of Staphylococcus aures strains isolated from patients attending regional referral hospitals in Tanzania.</p><p><strong>Methodology: </strong>A laboratory-based cross-sectional study using short read-based sequencing technology, (Nextseq550,Illumina, Inc. San diego, California, USA). The samples used were collected from patients attending selected regional referral hospitals in Tanzania under the SeqAfrica project. Sequences were analyzed using tools available in the center for genomic and epidemiology server, and visualization of the phylogenetic tree was performed in ITOL 6.0. SPSS 28.0 was used for statistical analysis.</p><p><strong>Results: </strong>Among 103 sequences of S. aureus, 48.5% (50/103) carry the mecA gene for MRSA. High proportions of MRSA were observed among participants aged between 18 and 34 years (52.4%), in females (54.3%), and among outpatients (60.5%). The majority of observed MRSA carried plasmids rep5a (92.0%), rep16 (90.0%), rep7c (90.0%), rep15 (82.0%), rep19 (80.0%) and rep10 (72.0%). Among all plasmids observed rep5a, rep16, rep20, and repUS70 carried the blaZ gene, rep10 carried the erm(C) gene and rep7a carried the tet(K) gene. MLST and phylogeny analysis reveal high diversity among MRSA. Six different clones were observed circulating at selected regional hospitals and MRSA with ST8 was dominant.</p><p><strong>Conclusion: </strong>The study reveals a significant presence of MRSA in Staphylococcus aureus strains from Tanzanian regional hospitals, with nearly half carrying the mecA gene. MRSA is notably prevalent among young adults, females, and outpatients, showing high genetic diversity and dominance of ST8. Various plasmids carrying resistance genes indicate a complex resistance profile, highlighting the need for targeted interventions to manage MRSA infections in Tanzania.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"211"},"PeriodicalIF":2.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revealing differential expression patterns of piRNA in FACS blood cells of SARS-CoV-2 infected patients. 揭示 SARS-CoV-2 感染者 FACS 血细胞中 piRNA 的不同表达模式。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-14 DOI: 10.1186/s12920-024-01982-9
Kirill A Kondratov, Alexander A Artamonov, Yuri V Nikitin, Anastasiya A Velmiskina, Vladimir Yu Mikhailovskii, Sergey V Mosenko, Irina A Polkovnikova, Anna Yu Asinovskaya, Svetlana V Apalko, Natalya N Sushentseva, Andrey M Ivanov, Sergey G Scherbak
{"title":"Revealing differential expression patterns of piRNA in FACS blood cells of SARS-CoV-2 infected patients.","authors":"Kirill A Kondratov, Alexander A Artamonov, Yuri V Nikitin, Anastasiya A Velmiskina, Vladimir Yu Mikhailovskii, Sergey V Mosenko, Irina A Polkovnikova, Anna Yu Asinovskaya, Svetlana V Apalko, Natalya N Sushentseva, Andrey M Ivanov, Sergey G Scherbak","doi":"10.1186/s12920-024-01982-9","DOIUrl":"10.1186/s12920-024-01982-9","url":null,"abstract":"<p><p>Non-coding RNA expression has shown to have cell type-specificity. The regulatory characteristics of these molecules are impacted by changes in their expression levels. We performed next-generation sequencing and examined small RNA-seq data obtained from 6 different types of blood cells separated by fluorescence-activated cell sorting of severe COVID-19 patients and healthy control donors. In addition to examining the behavior of piRNA in the blood cells of severe SARS-CoV-2 infected patients, our aim was to present a distinct piRNA differential expression portrait for each separate cell type. We observed that depending on the type of cell, different sorted control cells (erythrocytes, monocytes, lymphocytes, eosinophils, basophils, and neutrophils) have altering piRNA expression patterns. After analyzing the expression of piRNAs in each set of sorted cells from patients with severe COVID-19, we observed 3 significantly elevated piRNAs - piR-33,123, piR-34,765, piR-43,768 and 9 downregulated piRNAs in erythrocytes. In lymphocytes, all 19 piRNAs were upregulated. Monocytes were presented with a larger amount of statistically significant piRNA, 5 upregulated (piR-49039 piR-31623, piR-37213, piR-44721, piR-44720) and 35 downregulated. It has been previously shown that piR-31,623 has been associated with respiratory syncytial virus infection, and taking in account the major role of piRNA in transposon silencing, we presume that the differential expression patterns which we observed could be a signal of indirect antiviral activity or a specific antiviral cell state. Additionally, in lymphocytes, all 19 piRNAs were upregulated.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"212"},"PeriodicalIF":2.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs. 受抗逆转录病毒药物控制的艾滋病病毒感染者肠道微生物组中胰岛素敏感性相关类群的大量减少。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-13 DOI: 10.1186/s12920-024-01978-5
Eugeni Belda, Jacqueline Capeau, Jean-Daniel Zucker, Emmanuelle Le Chatelier, Nicolas Pons, Florian Plaza Oñate, Benoit Quinquis, Rohia Alili, Soraya Fellahi, Christine Katlama, Karine Clément, Bruno Fève, Stéphane Jaureguiberry, Cécile Goujard, Olivier Lambotte, Joël Doré, Edi Prifti, Jean-Philippe Bastard
{"title":"Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs.","authors":"Eugeni Belda, Jacqueline Capeau, Jean-Daniel Zucker, Emmanuelle Le Chatelier, Nicolas Pons, Florian Plaza Oñate, Benoit Quinquis, Rohia Alili, Soraya Fellahi, Christine Katlama, Karine Clément, Bruno Fève, Stéphane Jaureguiberry, Cécile Goujard, Olivier Lambotte, Joël Doré, Edi Prifti, Jean-Philippe Bastard","doi":"10.1186/s12920-024-01978-5","DOIUrl":"10.1186/s12920-024-01978-5","url":null,"abstract":"<p><strong>Background: </strong>Persons living with HIV (PWH) harbor an altered gut microbiome (higher abundance of Prevotella and lower abundance of Bacillota and Ruminococcus lineages) compared to non-infected individuals. Some of these alterations are linked to sexual preference and others to the HIV infection. The relationship between these lineages and metabolic alterations, often present in aging PWH, has been poorly investigated.</p><p><strong>Methods: </strong>In this study, we compared fecal metagenomes of 25 antiretroviral-treatment (ART)-controlled PWH to three independent control groups of 25 non-infected matched individuals by means of univariate analyses and machine learning methods. Moreover, we used two external datasets to validate predictive models of PWH classification. Next, we searched for associations between clinical and biological metabolic parameters with taxonomic and functional microbiome profiles. Finally, we compare the gut microbiome in 7 PWH after a 17-week ART switch to raltegravir/maraviroc.</p><p><strong>Results: </strong>Three major enterotypes (Prevotella, Bacteroides and Ruminococcaceae) were present in all groups. The first Prevotella enterotype was enriched in PWH, with several of characteristic lineages associated with poor metabolic profiles (low HDL and adiponectin, high insulin resistance (HOMA-IR)). Conversely butyrate-producing lineages were markedly depleted in PWH independently of sexual preference and were associated with a better metabolic profile (higher HDL and adiponectin and lower HOMA-IR). Accordingly with the worst metabolic status of PWH, butyrate production and amino-acid degradation modules were associated with high HDL and adiponectin and low HOMA-IR. Random Forest models trained to classify PWH vs. control on taxonomic abundances displayed high generalization performance on two external holdout datasets (ROC AUC of 80-82%). Finally, no significant alterations in microbiome composition were observed after switching to raltegravir/maraviroc.</p><p><strong>Conclusion: </strong>High resolution metagenomic analyses revealed major differences in the gut microbiome of ART-controlled PWH when compared with three independent matched cohorts of controls. The observed marked insulin resistance could result both from enrichment in Prevotella lineages, and from the depletion in species producing butyrate and involved into amino-acid degradation, which depletion is linked with the HIV infection.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"209"},"PeriodicalIF":2.1,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer. 探索细胞周期相关基因 CHMP4C 在前列腺癌中的临床和生物学意义。
IF 2.1 4区 医学
BMC Medical Genomics Pub Date : 2024-08-13 DOI: 10.1186/s12920-024-01970-z
Xi Xiao, Zonglin Li, Qingchao Li, Liangliang Qing, Yanan Wang, Fuxiang Ye, Yajia Dong, Xiaoyu Di, Jun Mi
{"title":"Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer.","authors":"Xi Xiao, Zonglin Li, Qingchao Li, Liangliang Qing, Yanan Wang, Fuxiang Ye, Yajia Dong, Xiaoyu Di, Jun Mi","doi":"10.1186/s12920-024-01970-z","DOIUrl":"10.1186/s12920-024-01970-z","url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer (PCa) stands as the second most prevalent malignancy impacting male health, and the disease's evolutionary course presents formidable challenges in the context of patient treatment and prognostic management. Charged multivesicular body protein 4 C (CHMP4C) participates in the development of several cancers by regulating cell cycle functions. However, the role of CHMP4C in prostate cancer remains unclear.</p><p><strong>Methods: </strong>In terms of bioinformatics, multiple PCa datasets were employed to scrutinize the expression of CHMP4C. Survival analysis coupled with a nomogram approach was employed to probe into the prognostic significance of CHMP4C. Gene set enrichment analysis (GSEA) was conducted to interrogate the functional implications of CHMP4C. In terms of cellular experimentation, the verification of RNA and protein expression levels was executed through the utilization of qRT-PCR and Western blotting. Upon the establishment of a cell line featuring stable CHMP4C knockdown, a battery of assays, including Cell Counting Kit-8 (CCK-8), wound healing, Transwell, and flow cytometry, were employed to discern the impact of CHMP4C on the proliferation, migration, invasion, and cell cycle function of PCa cells.</p><p><strong>Results: </strong>The expression of CHMP4C exhibited upregulation in both PCa cells and tissues, and patients demonstrating elevated CHMP4C expression levels experienced a notably inferior prognosis. The nomogram, constructed using CHMP4C along with clinicopathological features, demonstrated a commendable capacity for prognostic prediction. CHMP4C knockdown significantly inhibited the proliferation, migration, and invasion of PCa cells (LNcaP and PC3). CHMP4C could impact the advancement of the PCa cell cycle, and its expression might be regulated by berberine. Divergent CHMP4C expression among PCa patients could induce alterations in immune cell infiltration and gene mutation frequency.</p><p><strong>Conclusions: </strong>Our findings suggest that CHMP4C might be a prognostic biomarker in PCa, potentially offering novel perspectives for the advancement of precision therapy for PCa.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"210"},"PeriodicalIF":2.1,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信